Patents by Inventor Sydney David Cullis-Hill

Sydney David Cullis-Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for coronavirus infection and associated cytokine toxicity
    Patent number: 11938146
    Abstract: The present invention relates to novel methods for treating or preventing coronavirus infection and cytokine-associated toxicity, including cytokine toxicity resulting from aberrant activation of the immune system in coronavirus disease or infection, such as those from SARS-CoV-2.
    Type: Grant
    Filed: November 30, 2022
    Date of Patent: March 26, 2024
    Inventor: Sydney David Cullis-Hill
  • TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE TOXICITY
    Publication number: 20230201250
    Abstract: The present invention relates to novel methods for treating or preventing coronavirus infection and cytokine-associated toxicity, including cytokine toxicity resulting from aberrant activation of the immune system in coronavirus disease or infection, such as those from SARS-CoV-2.
    Type: Application
    Filed: November 30, 2022
    Publication date: June 29, 2023
    Inventor: Sydney David Cullis-Hill
  • TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE TOXICITY
    Publication number: 20230120864
    Abstract: The present invention relates to novel methods comprising the administration of pentosan polysulfate for treating or preventing coronavirus infection and cytokine-associated toxicity, including cytokine toxicity resulting from aberrant activation of the immune system in coronavirus disease or infection, such as those from SARS-CoV-2.
    Type: Application
    Filed: March 12, 2021
    Publication date: April 20, 2023
    Inventor: Sydney David Cullis-Hill